Alzheimer's Association[Grants and Funding] - Search Results

Year	Number of Results
2016	2
2017	8
2018	54
2019	66
2020	75
2021	79
2022	98
2023	190
2024	196

1

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment.

Chandra A, Valkimadi PE, Pagano G, Cousins O, Dervenoulas G, Politis M; Alzheimer's Disease Neuroimaging Initiative. Chandra A, et al. Hum Brain Mapp. 2019 Dec 15;40(18):5424-5442. doi: 10.1002/hbm.24782. Epub 2019 Sep 14. Hum Brain Mapp. 2019. PMID: 31520513 Free PMC article. Review.

2

Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.

Rangaraju S, Dammer EB, Raza SA, Rathakrishnan P, Xiao H, Gao T, Duong DM, Pennington MW, Lah JJ, Seyfried NT, Levey AI. Rangaraju S, et al. Mol Neurodegener. 2018 May 21;13(1):24. doi: 10.1186/s13024-018-0254-8. Mol Neurodegener. 2018. PMID: 29784049 Free PMC article.

3

Biomarkers for sepsis: more than just fever and leukocytosis-a narrative review.

Barichello T, Generoso JS, Singer M, Dal-Pizzol F. Barichello T, et al. Crit Care. 2022 Jan 6;26(1):14. doi: 10.1186/s13054-021-03862-5. Crit Care. 2022. PMID: 34991675 Free PMC article. Review.

4

The Vascular-Immune Hypothesis of Alzheimer's Disease.

Mehta RI, Mehta RI. Mehta RI, et al. Biomedicines. 2023 Jan 30;11(2):408. doi: 10.3390/biomedicines11020408. Biomedicines. 2023. PMID: 36830944 Free PMC article. Review.

5

Regulatory miRNAs in Cardiovascular and Alzheimer's Disease: A Focus on Copper.

Sacco A, Martelli F, Pal A, Saraceno C, Benussi L, Ghidoni R, Rongioletti M, Squitti R. Sacco A, et al. Int J Mol Sci. 2022 Mar 19;23(6):3327. doi: 10.3390/ijms23063327. Int J Mol Sci. 2022. PMID: 35328747 Free PMC article. Review.

6

LATE-NC in Alzheimer's disease: Molecular aspects and synergies.

Tomé SO, Gawor K, Thal DR. Tomé SO, et al. Brain Pathol. 2023 Oct 4:e13213. doi: 10.1111/bpa.13213. Online ahead of print. Brain Pathol. 2023. PMID: 37793659 Review.

7

Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.

Long JM, Coble DW, Xiong C, Schindler SE, Perrin RJ, Gordon BA, Benzinger TLS, Grant E, Fagan AM, Harari O, Cruchaga C, Holtzman DM, Morris JC. Long JM, et al. Brain. 2022 Dec 19;145(12):4506-4518. doi: 10.1093/brain/awac250. Brain. 2022. PMID: 35867858 Free PMC article.

8

COVID-19 and the impact on Alzheimer's disease pathology.

Furman S, Green K, Lane TE. Furman S, et al. J Neurochem. 2023 Oct 18:10.1111/jnc.15985. doi: 10.1111/jnc.15985. Online ahead of print. J Neurochem. 2023. PMID: 37850241 Review.

9

Brainstem substructures and cognition in prodromal Alzheimer's disease.

Dutt S, Li Y, Mather M, Nation DA; Alzheimer’s Disease Neuroimaging Initiative. Dutt S, et al. Brain Imaging Behav. 2021 Oct;15(5):2572-2582. doi: 10.1007/s11682-021-00459-y. Epub 2021 Mar 1. Brain Imaging Behav. 2021. PMID: 33646514 Free PMC article.

10

Cellular Senescence and Iron Dyshomeostasis in Alzheimer's Disease.

Masaldan S, Belaidi AA, Ayton S, Bush AI. Masaldan S, et al. Pharmaceuticals (Basel). 2019 Jun 19;12(2):93. doi: 10.3390/ph12020093. Pharmaceuticals (Basel). 2019. PMID: 31248150 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

677 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

677 results

Results by year